Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Udenafil Once-Daily for Erectile Dysfunction
NCT01774864Phase 3Completed
- Sponsor
- Dong-A Pharmaceutical
- Start
- Apr 2011
- Primary completion
- May 2012
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of udenafil in erectile dysfunction (ED) (3 arms), sponsored by Dong-A Pharmaceutical. Primary endpoint: International Index of Erectile Function - Erectile Function Domain Score at 24 weeks. Started Apr 2011; status: completed.
02
Drugs
udenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT01774864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01774864.